233 related articles for article (PubMed ID: 30991923)
1. Current strategies for therapeutic drug delivery after traumatic CNS injury.
Lee HJ; Ryu JS; Vig PJ
Ther Deliv; 2019 Apr; 10(4):251-263. PubMed ID: 30991923
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in therapeutic drug delivery systems for treatment of traumatic CNS injuries.
Khadka B; Lee JY; Kim KT; Bae JS
Future Med Chem; 2020 Oct; 12(19):1759-1778. PubMed ID: 33028091
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-based therapeutics in central nervous system injuries.
Sun P; Liu DZ; Jickling GC; Sharp FR; Yin KJ
J Cereb Blood Flow Metab; 2018 Jul; 38(7):1125-1148. PubMed ID: 29708005
[TBL] [Abstract][Full Text] [Related]
4. Advanced Therapies for Traumatic Central Nervous System Injury: Delivery Strategy Reinforced Efficient Microglial Manipulation.
Huang T; Wu J; Mu J; Gao J
Mol Pharm; 2023 Jan; 20(1):41-56. PubMed ID: 36469398
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.
Poniatowski ŁA; Wojdasiewicz P; Krawczyk M; Szukiewicz D; Gasik R; Kubaszewski Ł; Kurkowska-Jastrzębska I
Mol Neurobiol; 2017 Apr; 54(3):2167-2188. PubMed ID: 26927660
[TBL] [Abstract][Full Text] [Related]
6. Integrated Stress Response as a Therapeutic Target for CNS Injuries.
Romero-Ramírez L; Nieto-Sampedro M; Barreda-Manso MA
Biomed Res Int; 2017; 2017():6953156. PubMed ID: 28536699
[TBL] [Abstract][Full Text] [Related]
7. Nanowired drug delivery to enhance neuroprotection in spinal cord injury.
Tian ZR; Sharma A; Nozari A; Subramaniam R; Lundstedt T; Sharma HS
CNS Neurol Disord Drug Targets; 2012 Feb; 11(1):86-95. PubMed ID: 22385571
[TBL] [Abstract][Full Text] [Related]
8. Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.
Rodriguez-Grande B; Ichkova A; Lemarchant S; Badaut J
AAPS J; 2017 Nov; 19(6):1615-1625. PubMed ID: 28905273
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
Chakrabarti M; Das A; Samantaray S; Smith JA; Banik NL; Haque A; Ray SK
Rev Neurosci; 2016 Apr; 27(3):271-81. PubMed ID: 26461840
[TBL] [Abstract][Full Text] [Related]
10. Methods of Drug Delivery in Neurotrauma.
Deng-Bryant Y; Readnower R; Leung LY; Tortella F; Shear D
Methods Mol Biol; 2016; 1462():89-100. PubMed ID: 27604714
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury.
Waggoner LE; Madias MI; Hurtado AA; Kwon EJ
AAPS J; 2021 Aug; 23(5):100. PubMed ID: 34401968
[TBL] [Abstract][Full Text] [Related]
12. Nano-drug delivery and neuroprotection in spinal cord injury.
Sharma HS; Ali S; Tian ZR; Patnaik R; Patnaik S; Lek P; Sharma A; Lundstedt T
J Nanosci Nanotechnol; 2009 Aug; 9(8):5014-37. PubMed ID: 19928182
[TBL] [Abstract][Full Text] [Related]
13. Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration.
Xu D; Wu D; Qin M; Nih LR; Liu C; Cao Z; Ren J; Chen X; He Z; Yu W; Guan J; Duan S; Liu F; Liu X; Li J; Harley D; Xu B; Hou L; Chen ISY; Wen J; Chen W; Pourtaheri S; Lu Y
Adv Mater; 2019 Aug; 31(33):e1900727. PubMed ID: 31125138
[TBL] [Abstract][Full Text] [Related]
14. Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug Development.
Thelin EP; Carpenter KL; Hutchinson PJ; Helmy A
AAPS J; 2017 Mar; 19(2):367-376. PubMed ID: 28070712
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord.
Sharma HS; Ali SF; Dong W; Tian ZR; Patnaik R; Patnaik S; Sharma A; Boman A; Lek P; Seifert E; Lundstedt T
Ann N Y Acad Sci; 2007 Dec; 1122():197-218. PubMed ID: 18077574
[TBL] [Abstract][Full Text] [Related]
16. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties.
Pandya JD; Musyaju S; Modi HR; Okada-Rising SL; Bailey ZS; Scultetus AH; Shear DA
J Transl Med; 2024 Feb; 22(1):167. PubMed ID: 38365798
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
[TBL] [Abstract][Full Text] [Related]
19. Differential Response in Novel Stem Cell Niches of the Brain after Cervical Spinal Cord Injury and Traumatic Brain Injury.
Falnikar A; Stratton J; Lin R; Andrews CE; Tyburski A; Trovillion VA; Gottschalk C; Ghosh B; Iacovitti L; Elliott MB; Lepore AC
J Neurotrauma; 2018 Sep; 35(18):2195-2207. PubMed ID: 29471717
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in traumatic brain injury and central nervous system trauma.
Raad M; Nohra E; Chams N; Itani M; Talih F; Mondello S; Kobeissy F
Neuroscience; 2014 Dec; 281():16-23. PubMed ID: 25220901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
